Stay updated on Daratumumab in PGNMID and C3 GN Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in PGNMID and C3 GN Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.3.4, replacing Revision: v3.3.3. No substantive content or layout changes are evident.
    Difference
    0.1%
    Check dated 2026-01-16T06:40:06.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Minnesota as a location under the Locations section and removed the HHS Vulnerability Disclosure text/link from the footer.
    Difference
    0.2%
    Check dated 2025-12-18T12:24:07.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Added: a note that publications are automatically filled from PubMed and may not be about the study, and a new revision tag (v3.3.2); removed the older PubMed-origin text and the earlier revision tag (v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:48:44.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Removed a general government funding status notice from the page. The notice previously informed users about potential delays and updates due to funding and operating status of NIH facilities.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:57.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The new version shows minor UI and formatting updates with no changes to the study's core details (eligibility, outcomes, dosing, or locations).
    Difference
    0.4%
    Check dated 2025-11-03T20:58:46.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    4%
    Check dated 2025-10-06T05:27:09.000Z thumbnail image

Stay in the know with updates to Daratumumab in PGNMID and C3 GN Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in PGNMID and C3 GN Clinical Trial page.